JAMES TILL: Open Payments
NPI 1063605202 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 44 payments from 14 companies in 2025. Trend: 2023 $940 · 2024 $801 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 9 | $196 |
| Janssen Biotech, Inc. | 8 | $143 |
| UROGEN PHARMA, INC. | 4 | $135 |
| IMMUNITYBIO, INC. | 1 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| PFIZER INC. | 4 | $77 |
| Dendreon Pharmaceuticals LLC | 4 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| ABBVIE INC. | 2 | $44 |
| Laborie Medical Technologies Corp. | 1 | $23 |
Products named: XYOSTED, ERLEADA, ANKTIVA, JELMYTO, Nubeqa, XTANDI, PROVENGE, ORGOVYX.
Industry payments across LA — which companies pay providers there.
